Nuka Venkat Narender

Nuka Venkat Narender

Director Director DIN 01641941
DIN 01641941 First appointment Sep 1988 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Sep 1988
Shareholding value •••• Premium profile

About Nuka Venkat Narender

Data last updated:

Nuka Venkat Narender was a Director at Syntho Chirals Private Limited (2014–2019) and Director at Venmax Drugs And Pharmaceuticals Limited (1988–2021). The companies operate in Pharma.

DIN 01641941
Primary Designation Director
Industry Pharma
First Appointment 28 Sep 1988

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Syntho Chirals Private Limited U24239TG2004PTC043066
Director15 Nov 20142004₹162 Cr (FY 2024)Active
Director28 Sep 19881988₹1.86 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Syntho Chirals Private Limited
Venmax Drugs And Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Nuka Venkat Narender

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nuka Venkat Narender

Nuka Venkat Narender was first appointed on 28 Sep 1988 as Director at Venmax Drugs And Pharmaceuticals Limited. The most recent appointment on record is 15 Nov 2014 at Syntho Chirals Private Limited.

Nuka Venkat Narender held 2 earlier board appointments: Syntho Chirals Private Limited (Director, 15 Nov 2014 to 25 Nov 2019); Venmax Drugs And Pharmaceuticals Limited (Director, 28 Sep 1988 to 13 Feb 2021).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available